Verition Fund Management
ONCS

Verition Fund Management’s OncoSec Medical Incorporated ONCS Stock Holding History

Verition Fund Management’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-455
Closed -$18K – 1230
2019
Q4 		$18K Buy
+455
New +$20.6K ﹤0.01% 1030

Other funds holding ONCS

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return

Verition Fund Management's ONCS Position: Q1 2020 in Review

Verition Fund Management sold out of OncoSec Medical Incorporated (ONCS) in Q1 2020, closing a stake of 455 shares — an estimated $18K sold.

Verition Fund Management first reported a position in ONCS in Q4 2019 and held it in 1 quarter. The position peaked at $18K in Q4 2019. 20 funds tracked by Wall St. Rank hold ONCS as of Q1 2020.

  • Verition Fund Management reported no remaining OncoSec Medical Incorporated position as of Q1 2020 after selling out during the quarter.
  • Verition Fund Management sold 455 OncoSec Medical Incorporated shares in Q1 2020, an estimated $18K.
  • Verition Fund Management first reported a position in OncoSec Medical Incorporated in Q4 2019 and held it in 1 quarter.
  • Verition Fund Management's OncoSec Medical Incorporated position peaked at $18K in Q4 2019.
  • 20 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q1 2020.

Based on Verition Fund Management's 13F filing for Q1 2020, filed 15 May 2020.